Adial Pharmaceuticals, Inc. (ADIL) vs Lantern Pharma Inc. (LTRN)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.23HealthcareDelayed quote: Oct 6, 2026, 12:51 PM EDT
LTRN
Lantern Pharma Inc.
$0.96HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ADIL vs LTRN
growth of $100 · dividends reinvested · last 6yADIL -99.5% (-59.0%/yr)LTRN -93.7% (-36.9%/yr)LTRN compounded faster over this window
Log scale — wide-divergence pair
ADIL LTRN
ADIL vs LTRN: by the numbers
- •LTRN is the larger company ($12M vs $11M market cap).
Metrics side by side
Profitability
| Metric | ADIL | LTRN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37052.06% | N/A |
| ROIC | -240.64% | -358.04% |
Growth (annualized)
| Metric | ADIL | LTRN |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -37.05% |
Frequently asked
- How have ADIL and LTRN total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and LTRN delivered -37.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.